Lv11
30 积分 2024-06-13 加入
Validation and utility of HepG2 xenograft model for hepatocellular carcinoma
1小时前
待确认
Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A
2个月前
已完结
Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity
3个月前
已完结
Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
3个月前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
4个月前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
4个月前
已完结
CAR T-cell therapy in multiple myeloma: mission accomplished?
4个月前
已关闭
CAR T-cell therapy in multiple myeloma: mission accomplished?
4个月前
已关闭
Accelerating and optimising CAR T-cell manufacture to deliver better patient products
4个月前
已完结
Rapid manufacturing of CAR-T therapy: strategies and impact
4个月前
已完结
皖公网安备34019202002308
